Role of Apfel's Score in Predicting Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to assess the role of Apfel's score in predicting postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy in patients with symptomatic cholelithiasis. The main questions it aims to answer are:
- 1.Does Apfel's score accurately predict the occurrence of PONV after laparoscopic cholecystectomy?
- 2.Which components of Apfel's score are most strongly associated with PONV?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2023
CompletedFirst Submitted
Initial submission to the registry
October 30, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedNovember 4, 2024
October 1, 2024
11 months
October 30, 2024
October 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Postoperative Nausea and Vomiting (PONV)
The number of patients who experience nausea and/or vomiting within 24 hours after laparoscopic cholecystectomy.
Assessed for 24 hours post-surgery.
Secondary Outcomes (1)
Relationship Between Apfel's Score and PONV Incidence
Assessed for 24 hours post-surgery.
Eligibility Criteria
The study population consists of adult patients who are undergoing elective laparoscopic cholecystectomy for symptomatic cholelithiasis. These patients are treated at the Department of General Surgery at National Medical College Teaching Hospital, Birgunj, Nepal.
You may qualify if:
- Patients aged 18 to 90 years.
- Patient scheduled for elective laparoscopic cholecystectomy for symptomatic cholelithiasis.
- Patients who provided written informed consent to participate in the study.
You may not qualify if:
- Patients receiving prophylactic antiemetic medications prior to surgery.
- Patients on opioid analgesics for reasons other than the surgical procedure.
- Pregnant women.
- Patients whose laparoscopic cholecystectomy was converted to open cholecystectomy during the operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Medical College and Teaching Hospital, Birgunj
Birgunj, Madesh, Nepal, Nepal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 30, 2024
First Posted
November 1, 2024
Study Start
March 12, 2022
Primary Completion
February 6, 2023
Study Completion
October 28, 2023
Last Updated
November 4, 2024
Record last verified: 2024-10